Casandra
Casandra Test Code QD60562Version 1 (DRAFT)
Performing Lab
MDMA/MDA Screen, with Confirmation, Urine
Clinical Use
Order TestUse
This test performs an initial immunoassay-based screen for MDMA (ecstasy) and its metabolite MDA in urine; presumptive positive results are reflexed to confirmation testing using more specific and sensitive mass spectrometry methods such as LC–MS/MS. It is useful for detecting stimulant use in clinical, employment, or monitoring contexts.
Special Instructions
Not provided.
Limitations
Quantitative values cannot be used to infer dose because drugs like MDMA are extensively metabolized and excreted; only qualitative interpretation relative to cutoff values is appropriate.
Test Details
Methodology
Immunoassay (Multiplex Protein Panel)
Biomarkers
2 components
MDMA/MDA Screen (immunoassay) • Multiplex Protein PanelConfirmation (LC–MS/MS) • Multiplex Protein Panel
Result Turnaround Time
0 days
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Urine
Volume
Not provided
Minimum Volume
Not provided
Similar Tests
Other tests from different labs that may be relevant
MDMA, Screen and Confirmation, Urine
Labcorp
MDMA, Screen Only, Urine
Labcorp
MDMA Confirmation (Labcorp MedWatch®)
Labcorp
Mephedrone, MDPV, and Methylone, Screen and Confirmation, Urine
Labcorp
Mephedrone, MDPV and Methylone, Urine
Mayo Clinic Lab
Amphetamine Confirmation, Urine
Labcorp
Drug Panel 7A, Urine - Screen with Reflex to Confirmation/Quantitation
ARUP Laboratories
LSD, Urine - Screen with Reflex to Confirmation/Quantitation
ARUP Laboratories